| 000 | 00889 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514053925.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1476-5608 | ||
| 024 | 7 |
_a10.1038/sj.pcan.4500520 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeters, J L | |
| 245 | 0 | 0 |
_aBone loss associated with the use of LHRH agonists in prostate cancer. _h[electronic resource] |
| 260 |
_bProstate cancer and prostatic diseases _c2001 |
||
| 300 |
_a161-166 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aFairney, A | |
| 700 | 1 | _aKyd, P | |
| 700 | 1 | _aPatel, A | |
| 700 | 1 | _aRogers, S | |
| 700 | 1 | _aWebster, J J | |
| 700 | 1 | _aVale, J A | |
| 700 | 1 | _aWitherow, R O N | |
| 773 | 0 |
_tProstate cancer and prostatic diseases _gvol. 4 _gno. 3 _gp. 161-166 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.pcan.4500520 _zAvailable from publisher's website |
| 999 |
_c12300919 _d12300919 |
||